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Medical prognostic models can be designed to predict the future course or outcome of disease progres-
sion after diagnosis or treatment. The existing variable selection methods may be precluded by full model
advocates when we build a prediction model owing to their estimation bias and selection bias in right-
censored time-to-event data. If our objective is to optimize predictive performance by some criterion, we
can often achieve a reduced model that has a little bias with low variance, but whose overall performance
is enhanced. To accomplish this goal, we propose a new variable selection approach that combines Step-
wise Tuning in the Maximum Concordance Index (STMC) with Forward Nested Subset Selection (FNSS) in
two stages. In the ﬁrst stage, the proposed variable selection is employed to identify the best subset of
risk factors optimized with the concordance index using inner cross-validation for optimism correction
in the outer loop of cross-validation, yielding potentially different ﬁnal models for each of the folds.
We then feed the intermediate results of the prior stage into another selection method in the second
stage to resolve the overﬁtting problem and to select a ﬁnal model from the variation of predictors in
the selected models. Two case studies on relatively different sized survival data sets as well as a simula-
tion study demonstrate that the proposed approach is able to select an improved and reduced average
model under a sufﬁcient sample and event size compared with other selection methods such as stepwise
selection using the likelihood ratio test, Akaike Information Criterion (AIC), and lasso. Finally, we achieve
better ﬁnal models in each dataset than their full models by most measures. These results of the model
selection models and the ﬁnal models are assessed in a systematic scheme through validation for the
independent performance.
 2011 Elsevier Inc. All rights reserved.1. Introduction
Medical prognostic models can be designed to predict the fu-
ture course or outcome of disease progression after diagnosis or
treatment. Such models can provide individualized predictions
about the characteristics of one single patient. However, there is
considerable uncertainty within the statistical modeling commu-
nity regarding how best to develop an accurate prediction model
for censored survival data. Speciﬁcally, when it comes to variable
selection, some advocate ﬁtting the full model [1] in which predic-
tors are pre-speciﬁed with external information from the litera-
ture, while variable selection methods remain popular [2,3].
Nonetheless, a full model may be large and complicated to be used
as a statistical tool. There is little literature comparing these pri-
mary approaches with respect to the predictive accuracy in cen-
sored clinical data. Logistic regression models [3–6] have beenll rights reserved.
WELLSB@ccf.org (B.J. Wells),studies for clinical models. If the goal is to optimize predictive
accuracy for ﬁnding a set of reduced prognostic factors, a plausible
alternative to the full model would be to ﬁt the most accurate, pos-
sibly reduced, model. An argument can easily be made for a parsi-
monious model that is at least as accurate as the full model.
In general, the complexity of a model obtained by a procedure
of variable selection is expected to be less than that of the full
model, and the variance of the estimated parameters should be
lower. Nevertheless, recent studies emphasize the limitations of
variable selection, such as bias in the estimates of parameters (esti-
mation bias) and the lack of stability in an iterative scheme of var-
iable selection [4]. In a stable algorithm, the effect of
computational error during the iteration is no worse than that of
a small amount of input data error from multi-collinearity [7,8].
The unstable variable selection algorithm may enlarge initial per-
turbations after numerous iterations. Furthermore, in variable
selection, multi-collinearity between the omitted variables and
the selected variables can cause selection bias. Dropping inﬂuential
variables from the effective model results in underﬁtting to data
with increased residuals and biased parameter estimates for
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the effective model induces overﬁtting and increases the variance
of parameter estimates for correlated predictors [9]. We attempt
to reduce the instability and increase the reliability of the selection
algorithm using the resampling method of cross-validation [10].
A large sample size is the need for a problem of ﬁtting the full
model with numerous and complicated predictors to obtain unbi-
ased estimation in model ﬁtting, and the possibility of overﬁtting
due to model complexity. The sample size problem due to the
model complexity can be accounted for by the curse of dimension-
ality [11]. In fact, regression modeling with time-to-event data is
much more sensitive to the events per variable (EPV) [12] than
the overall sample size. Some researchers carefully guide the EPV
ratio to estimate bias and sometimes suggest using shrinkage of
the coefﬁcient estimates [4]. However, highly correlated features
in this situation may produce high variance, even if there is no esti-
mation bias according to the EPV. Hence, this guidance is crucial to
model building at the developing step.
The last challenging characteristic of clinical survival data, to
tackle in variable selection, is right censoring. There are two types
of censoring in classical survival models: (i) Type I: survival until
the end of study but whose ﬁnal event time is unknown; (ii) Type
II: lost to follow-up after a certain time. Even though data are
incomplete, they contain a certain amount of information to in-
crease the sample size and thus improve performance of the mod-
el. However, with the presence of censoring, the behavior of the
underlying mechanism produces unclear performance measure-
ments of models and may lead to biased results in variable selec-
tion. In survival analysis, Cox regression models are commonly
used and one of the major advantages is the ability to utilize cen-
sored observations. We use the Cox proportional hazards model
[13,14] in this article. In order to consider the censoring in model
assessment, many performance measures, which summarize a
time dependency using integration [15,16] and are robust to cen-
soring [17], are introduced to quantify the prediction accuracy
and the amount of prognostic information represented by the
model; Some of these appear in Section 3.2. However, among them,
maximizing the C-Index has some patterns to enhance other mea-
sures along with it and some merits (see Section 4). As a predictive
accuracy, the C-Index is a preferred choice in this study.
Fig. 1 illustrates the optimization path with the initial point of a
full model in a variable selection procedure of this study. The selec-
tion methods start from the full model, which is a type of single ﬁ-
nal model, and select the best model, optimized in some criterion.
The starting full models can be categorized into three groups
depending on the above challenges with the data involving the
event size, the model complexity, and the degrees of censoring:Pr
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Fig. 1. Types of initial full models in the optimization path to their ﬁnal models.(a–c) in Fig 1. The objective of model selection is to achieve the ﬁ-
nal model with optimal model complexity based on the prediction
accuracy while tuning the tradeoff between bias and variance. In
theory, the type (a) completes the course at (b), and in the types
of (b) and (c), the full model is the ﬁnal model, in which the differ-
ence is that in (c) the full model may suffer from a lack of data, ade-
quately signiﬁcant predictors, or high rate of right censoring at the
initial point.
The aim of this paper is to propose a novel approach that builds
a parsimonious model that is at least as accurate as the full model
with respect to the C-Index as an objective criteria. Herein, we pro-
pose a new approach to address these problems in two stages: (1)
Stepwise Tuning in the Maximum Concordance Index (STMC) as a
variable selection process within each set of training folds of outer
cross-validation using inner cross-validation for the optimism cor-
rection and (2) Forward Nested Subset Selection (FNSS) as overﬁt-
ting control, which reduces uncertainty and variability in the
predictors of chosen models resulting from STMC and builds a sin-
gle ﬁnal model. In the new approach, Cox proportional hazards
regression models with only main effect terms are used and ﬁtted
to two censored clinical data sets in the areas of renal transplanta-
tion and prostate cancer. For the comparative study of methods
and models, we employ the same scheme as the ﬁrst stage of our
approach to compare our proposed method against the alternatives
of the stepwise method that uses the likelihood ratio test and AIC
criterion and the lasso using an L1 absolute value penalty that has
two meritorious features of shrinkage and model selection [18,19].
Then, we compare the single ﬁnal model of a FNSS result with the
full model for ﬁnal model assessment.
Section 2 describes two clinical data sets. In Section 3, we deﬁne
censored data and performance measures for prediction models
and present our new approach for the selection of a reduced and
accurate model. In Section 4, our methods are applied to the two
data sets and we compare the results. In Section 5, we discuss lim-
itations, further studies, and provide concluding remarks.2. Data sets
2.1. Prostate cancer data
We procured data from a study that created a post-operative
nomogram for predicting the risk of prostate cancer recurrence
[20] following institutional Review Board waivers (Cleveland Clinic
IRB number: 4270). The cohort consists of a total of 1123 patients
(with 167 biochemical recurrences) with clinically localized pros-
tate cancer treated with open radical retropubic prostatectomy be-
tween 1987 and 2003. The seven predictors in the full model
include the following categorical variables: (1) seminal vesicle
involvement (svi), (2) surgical margins (sm), (3) lymph node
involvement (lni) and (4) extra-capsular extension (ece), and the
continuous variables: (5) prostate speciﬁc antigen (psa), (6) expe-
rience (surgery experience), and (7) post-operative Gleason sum
(pgx) which is treated as an ordinal type variable. In [21], the full
model is pre-speciﬁed based on medical literature reviews and
clinical knowledge of investigators and surgeons prior to an analy-
sis of the data. For the further detail of the description of the data,
see [21]. Two missing values in psa are imputed using the R MICE
package in the study and other variables are complete. Patients
who are lost to follow-up or died from causes other than prostate
cancer are right-censored. Table 1 shows the statistical description
of the prostate cancer recurrence data in our study, and the esti-
mated coefﬁcients and statistical signiﬁcance of the predictors in
a multivariable Cox proportional hazards regression ﬁtted to the
entire data set for the full model and the ﬁnal model built from
the proposed method, which predict the 10-year probability of
Table 1
Description of prostate cancer data (1123 patients), and estimated coefﬁcients and
statistical signiﬁcance of predictors in a multivariable Cox proportional hazards
model ﬁtted to the entire data for the full model and the ﬁnal model built by the
proposed method. b^full , estimated log-relative risk (full model, seven predictors); Pfull,
p-values of full model;b^x , estimated log-relative risk (model M: STMC + FNSS, ﬁve
predictors); PM, p-values of M.
Predictor No. (%) b^full Pfull b^M PM
Pathology Gleason sum 0.95 <0.00001 0.92 <0.00001
4–6 449 (40)
7 621 (55)
8–10 53 (5)
Extra capsular
extension (yes)
389 (35) 0.92 <0.00001 0.95 <0.00001
Surgical margin (yes) 297 (26) 0.63 0.00019 0.65 <0.00011
Seminal vesicle
involvement (yes)
89 (8) 0.29 0.19 0.42 <0.048
Lymph node status
(positive)
23 (2) 0.56 0.048
PSA* (ng/mL) (0.5) 7.6
(94.5)
0.02 0.033 0.02 0.0066
Surgery experience* (0) 679.2
(1336)
0.00 0.67
* Continuous variable: (Min) Mean (Max).
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and rising, or a secondary treatment for a detectable and rising PSA
less than or equal to 0.4 ng/mL.
2.2. Renal transplantation data
Renal transplantation data was obtained from the United Net-
works for Organ Sharing (UNOS) Registry for chronic kidney dis-
ease from 2000 to 2003 [22]. The cohort includes 20085 living
donor renal transplant cases with 2300 documented graft failures.
This data is used to form pre-transplant and post-transplant nomo-
grams that predict 5-year graft failure in [22], in which all patients
received kidney transplant as a primary treatment for renal failure
and are then followed for signs of the transplant failure. The out-
come of transplant failure is deﬁned as a recurrence of kidney dis-
ease within 5 years of transplant. In the study, the predictor
variables for the full models are chosen by clinicians based on their
theoretical association with graft failure in the clinical literature.
Our study is based on the post-operative nomogram [22] and
we use the data with 22 variables selected based on the full model
[22] that is speciﬁed by clinicians from the 67 original predictor
variables, which include some measurements before and after
the time of the renal transplant. The predictors consists of demo-
graphical information of donors and recipients: age, gender, race
(black, white, and others); pathological information: Body Mass In-
dex (bmi), Donor Serum Creatinine Pre-transplant (SCr), Donor
Procedure: Nephrectomy Type, Human Lymphocyte Antigen
(HLA) mismatch level, Dialysis in the ﬁrst week, any treatment
for rejection within ﬁrst 6 months, Estimated Glomerula Filtration
Rate (eGFR)-MDRD (Modiﬁcation of Diet in Renal Disease) after
6 months of transplant, Adjuvant chemotherapy on the use of
immunosuppressants: (Azathioprine, Rapamicine (Sirolimus),
Mycophenolate Mofetil), IL2 Receptor Antibodies, Calcineurin
Inhibitor without fk506, and Induction with Depleting Antibodies.
The race variables of donors and recipients have a categorical type
and are processed using dummy variables and HLA Mismatch is
treated as an ordinal type. No missing values are identiﬁed.
The ﬁnal predictive model predicts the 5-year graft survival
probability after living donor kidney transplant. Table 2 further de-
scribes the above predictors and multivariate analysis used for the
pre-speciﬁed full model of the multivariable Cox model and the ﬁ-
nal model resulting from the proposed method.3. Methods
3.1. Censored data and Cox regression
Censored survival data is deﬁned as zi = ti, di, xi for n independent
individuals, ie{1,. . .,n}. The observed time, ti is given by ti=min(Ti,Ci),
where Ti is the time of event and Ci is the time of censoring. The
event indicator variable, di takes 1 if an event occurred at the ob-
served time (Ti 6 Ci), or a value of 0 if ti is censored, and xi is a p-vec-
tor of covariates, [xi1,xi2,. . .,xip]T, which is each row of the design
matrix X. The Cox proportional hazards model is deﬁned as
hðt jj xiÞ ¼ h0ðtÞexpðxTi bÞ; ð1Þ
where h0(t) is a baseline hazard function and left unspeciﬁed with
h0(t)P 0. For an estimate of the baseline hazard h0(t), the Breslow
estimator is commonly used and given by
h^0ðtiÞ ¼ 1=Rtjti expðxTj bÞ ð2Þ
The vector of regression coefﬁcients, b is estimated by maximiz-
ing the partial log-likelihood (PLL)
PLLfullðbÞ ¼
Xn
i¼1
di xTi b log
X
tjti
expðxTj bÞ
0
@
1
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5: ð3Þ3.2. Performance evaluation of a model
There are many methods used to measure a statistical prognos-
tic model’s prediction accuracy. These are principally categorized
into (1) Discrimination, which measures how well the prediction
model can discriminate between cases with event and nonevent,
includes the time-dependent receiver operating characteristic
(ROC) curve [23], the concordance index (or C-statistic) [1,24],
and the Concordance Probability Estimates (CPE) [25]; (2) Calibra-
tion, which quantiﬁes how close a predicted estimate is to the real
probability, includes the calibration slope and curve; and lastly (3)
Overall score of the measures such as explained variation (R2 type
statistics and the Brier score) [16,26]. Some relatively new perfor-
mance measures for reclassiﬁcation and clinical usefulness are also
discussed as well as the above in [27] and they stress that a well-
discriminating model may be most relevant for research purposes,
suggesting that reporting discrimination and calibration is impor-
tant for a prediction model.
Our concern of this study is the prediction ability of a model as
above. Although the PLL is used for predictive inference and mod-
eling, it can also be used in the difference in deviances between a
ﬁtted model and the null model, given by 2(PLL(b)PLL(0)) as a
prediction error, for evaluating the performance on new data as
well as for the selection of complexity on training data. Thus, in
this article, we use some of the above accuracy measures, whose
results may directly be amenable to produce the empirical predic-
tion performance for new patients [28].
In addition, the variants of R2 statistic with censored data can be
deﬁned in several ways [16] and are sensitive to the rate of censor-
ing, and it is tricky to determine which type is proper for the com-
parisons due to the restriction of a censoring mechanism.
As above, the numerous predictive measures that exist have
advantages and disadvantages for survival analysis, but we would
not insist that there is one that is superior to the others and the
development of new measures is also an active area of research.
Hence, we use a few methods simultaneously in order to compare
the performances of the different model selection methods. The
performance measures that we utilize are described in the next
section.
Table 2
Description of renal transplant data (20,085 patients), and estimated coefﬁcients and statistical signiﬁcance of predictors in a multivariable Cox proportional hazards model ﬁtted
to the entire data for the full model and the ﬁnal model built by the proposed method. b^full , estimated log-relative risk (full model, 22 predictors); Pfull, p-values of full model;b^x ,
estimated log-relative risk (model M: STMC + FNSS, seven predictors); PM, p-values of M.
Characteristic Variables Description Mean (SD) or No. (%) b^full Pfull b^M PM
Recipient Age Recipient age (years) 46 (14) 0.003 0.129 0.424 <0.0001
Gender Recipient gender (female) 8320 (41) 0.05 0.242 0.0001 0.034
Race Recipient race 0.004 0.978
Black 2992 (15) 0.24 0.09
White 13,525 (67) 0.03 0.756
Others 3568 (18)
bmi 26.7 (5.4) 0.002 0.525
Donor AGE_DON Recipient Body Mass Index (kg/m2) 40 (10.8) 0.005 0.02
GENDER_DON Donor’s age (years) 11,806 (59) 0.003 0.941
Drace Donor’s gender (female)
Black Donor race 2767 (14) 0.174 0.233
White 13,876 (69) 0.022 0.834
Others 3442 (17)
d_bmi Donor’s BMI (kg/m2) 26.9 (4.7) 0.013 0.0029
d_creat Donor serum creatinine (SCr) pre-Tx(mg/dl) 0.9 (0.5) 0.081 0.148
d_procec Donor procedure: nephrectomy type 0.017
Laparoscopy 13,057 (65) 0.148
Open 7028 (35)
Recipient/Donor HLAMIS HLA mismatch level 0.021 0.106
0 2148 (11)
1 1262 (6.3)
2 3738 (19)
3 5739 (29)
4 2500 (13)
5 2956 (15)
6 1538 (7.7)
Adjuvant chemotherapy im_deple Induction with depleting antibodies(yes) 3731 (19) 0.013 0.817
im_il2 Induction with IL2 receptor antibodies (yes) 7604 (38) 0.013 0.77
im_aza Azathioprine maintenance (yes) 723 (4) 0.142 0.223
im_myco Mycophenolate Mofetil maintenance (yes) 15415 (77) 0.318 <0.0001
im_rapa Rapamycin(Sirolimus) maintenance (yes) 2960 (15) 0.324 <0.0001
im_calci Calcineurin inhibitor with fk506 (yes) 18729 (93) 0.934 <0.0001 0.903 0.00000
Recipient posttransplant dial_1wk Dialysis in the ﬁrst week (yes) 957 (5) 1.423 <0.0001 1.403 0.00000
trt_rej6 Any treated for rejection within 1st 6 months (Yes) 1861 (13) 0.425 <0.0001 0.423 0.00,000
gfr_po6 eGFR(MDRD) in 6 months (ml/min/1.73 m2) 56.5 (18) 0.025 <0.0001 0.025 0.00000
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The ROC curve for the discriminative ability is a standard tech-
nique to assess the sensitivity and 1-speciﬁcity in a binary classiﬁ-
cation rule [26] and is a plot of their values for all of the possible
cutoff values, c of the continuous variable, which is the risk score
R, such as prognostic index in survival analysis. The time-dependent
ROC curves was proposed to assess the predictive accuracy of a
survival model [23], deﬁned as
Sensitiv ityðc; tÞ ¼ PrfR > c j DðtÞ ¼ 1g; ð4Þ
Specificityðc; tÞ ¼ PrfR  c j DðtÞ ¼ 0g: ð5Þ
Here, Di(t) = 1 if Ti 6 t and Di(t) = 0 if Ti > t to represent the event sta-
tus of individual i at time t. The corresponding time-dependent ROC
curve and the time-dependent area under the ROC curve can be de-
ﬁned for time t as ROC(t) and AUC(t) respectively. The AUC(t) can be
summarized by the integrated area under the curve (IAUC), given by
the area under ROC(t) over event time. Like for the AUC, IAUC = 1
indicates the perfect prediction accuracy and IAUC = 0.5 is as good
as a random guess over time.
3.2.2. Concordance index (C-Index)
In survival analysis, one of the most popular performance mea-
sures for assessing models is the concordance index, which is sim-
ilar to the Wilcoxon–Mann–Whitney statistic in bi-partite ranking
problems [29]. The concordance index [1] is deﬁned, for the second
measure of the discriminative ability, asC-index ¼ Ri;jX1fti > tjgj X j ; ð6Þ
where 1{} is an indicator function given by 1 if the argument is true,
0 otherwise, and X is a set of all pairs of patients (i, j) that satisﬁes
one of the following: (i) the patients i and j experienced recurrence
and the recurrence time ti is shorter than tj, or (ii) only patient i
experienced recurrence and ti is shorter than the follow-up time
tj. In case of tied pairs, they have 1/2 weight for the instance as well
as denominator. The C-Index estimates the probability that given
two randomly drawn patients, the patient who has the event ﬁrst
had a higher probability of the event. The experienced recurrence
time of an individual in (6) can be replaced with the prognostic in-
dex (see the next subsection).
Although the C-Index is unable to represent evolutionary per-
formance over time, it is a generalization of the AUC(t) [15]. Also,
the researchers in [30] demonstrate that a method maximizing
the PLL ends up approximately maximizing the concordance index.
We have thus chosen the concordance index as the primary objec-
tive criterion in our proposed approach due to its popularity, inter-
pretability, simplicity, and robustness, though several measures in
this section will be utilized to compare methods and models.
3.2.3. Calibration slope and curve
Calibration can be examined by using the calibration slope and
calibration curve. The calibration slope b for survival data can be
computed by performing a Cox regression with the PI (prognostic
index) for a new data set, as a single continuous variable in the
Cox proportional hazards model as follows.
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Here, the prognostic index is a linear combination of the regression
coefﬁcients estimated in a training sample and the values of risk
factors in the test data. If the calibration slope is unity, the regres-
sion model is perfectly calibrated. Otherwise, the regression coefﬁ-
cients that are estimated in the training sample reﬂect
underestimation or overestimation. For the validity of the whole
model, however, we need to check that the correctness of the base-
line survival function as well [31] and the optimism corrected slope
can be considered as a shrinkage factor that takes overﬁtting into
account [24]. Calibration is also visually inspected by a calibration
curve which is a plot of groups divided by their equal sample sizes
and displays the accuracy between average predicted probabilities
vs. Kaplan–Meier estimates of actual outcomes.
For performance measures and model validation, two main con-
cepts of discrimination and calibration can be combined for a data
analysis. These can provide a complementary interpretation for
comparative analysis, when the overall score is suffering from a
censoring mechanism.
3.2.4. Integrated Brier Score (IBS)
For the inaccuracy of individual predictions, the censored brier
score is measured based on the squared difference between pre-
dicted and observed survival with censorship [32] and its empirical
version of time t can be deﬁned for n patients of multiple covariate
x with a censoring variable di and a time-to-event variable Ti as
follows.
CBSðtÞ ¼ 1
n
Xn
i¼1
ð0 p^ðt j xiÞÞ21ðTi  t; di ¼ 1Þ 1
G^ðTiÞ
 !(
þð1 p^ðt j xiÞÞ21ðTi > tÞ 1
G^ðtÞ
 !)
ð8Þ
where p^ðt j xiÞ is an estimated recurrence-free probability for a pa-
tient i, and G^ðtÞ is a probability of being censored and is calculated
by the Kaplan Meier estimate on (Ti, 1  di). The variable Ti has the
time value of an event recurrence when the event status of a patient
i, di is 1, or a censored time if di is 0. Note that the Brier score is 0 in
the perfect prediction and 0.25 when the trivial prediction of
p^ðtÞ ¼ 0:5 is made to all patients. The Integrated Brier Score (IBS)
is a summary of the prediction error over event time by integrating
the formula (8).
3.3. Stepwise variable selection and its criteria
For the comparison purpose with our proposed method, ﬁrst we
introduce the stepwise selection method started from the full
model using two different criteria, the likelihood ratio test and
Akaike Information Criterion (AIC) in Cox models.
3.3.1. Hypothesis test
In order to test the null hypothesis H0:b = b(0), where b(0) are the
coefﬁcients of the null model or nested smaller model with p0
parameters in contrast to the bigger model with the p1 parameters
of b, Wald test or the likelihood ratio test can be used to derive the
signiﬁcance of a variable for variable selection. The probability dis-
tribution of both test statistics is approximated by a chi-square dis-
tribution with (p1–p0) degrees of freedom.
3.3.1.1. Wald test. The Wald test statistic is written as
ðb^ bð0ÞÞT I^ðb^ bð0ÞÞ, where I^ ¼ Iðb^Þ is the estimated information
matrix, which is the second derivative of the log partial likelihood
(PLL) with respect to b. This reduces to the z-statistic b^
seðb^Þ, where
seðb^Þ is a standard error of b^, in a single variable [18,33].3.3.1.2. Likelihood ratio test (LRT). The likelihood test statistic is de-
ﬁned by 2ðPLLðb^Þ  PLLðb"ð0ÞÞÞ, where PLL(b^) and PLL(b(0)) are the
log partial likelihood of the bigger model and the nested smaller
model respectively. The likelihood test is generally more stable
than the Wald test, and therefore is used for the stepwise selection.
3.3.2. Stepwise selection in Cox model
The stepwise variable selection is a hybrid method in either
direction of two classic methods: (1) the forward selection method
and (2) the backward elimination method, and uses the signiﬁ-
cance of a variable as a criterion for selection. In Cox proportional
hazards regression models, the likelihood ratio test is used to com-
pute p-values. In the forward selection, it begins with the null
model and adds the predictor with the smallest p-value. This is re-
peated until no variable upon entry into the model has a p-value
less than a signiﬁcance level that is a parameter to be determined
in advance. If variables once entered are no longer signiﬁcant they
may be dropped off while candidate variables are added in the for-
ward approach. This step is repeated until the ﬁnal model has no
variables with p-values greater than or equal to the signiﬁcance le-
vel. For the backwards elimination, we start with the full model
and remove the variable with the largest p-value if it is larger than
the signiﬁcance level. We repeat this process until no variable in
the model has a p-value greater than or equal to a signiﬁcance le-
vel. The hybrid stepwise gives a second chance to each dropped
variable except the most recently dropped one. If this value is less
signiﬁcant than that of the dropped one and less than the signiﬁ-
cance level, the predictor is reintroduced in the current model of
the process. The hybrid stepwise is used in this article and we refer
to it as stepwise. As a selection level, the conventional quantity
0.05 is used.
3.3.3. AIC for variable selection
The AIC for variable selection is deﬁned by
AIC ¼ 2  PLLðbÞ þ 2  d; ð9Þ
where d is the effective number of parameters and given by the
number of parameters in a model. We simply choose the model giv-
ing the smallest AIC over the subsets of models considered in each
search space started from the full model. The AIC estimates predic-
tion errors in an analytical and intrinsic way that the optimism is
estimated directly from a training set and then this is added to
the training error. So the optimism correction using cross-validation
or bootstrapping is not required in such a criterion. Although future
inputs are not likely identical to training sets, this kind of error can
be used for the effective model selection due to its relative nature. It
turns out that the signiﬁcance level 0.157 in the backward elimina-
tion method usually chooses the variables that are selected by min-
imizing the AIC in all subset procedure when all variables have 1
degree of freedom [2].
3.4. Lasso
The last baseline method we choose for comparison is the L1
penalized estimation method, lasso [18,19] that shrinks the esti-
mates of the coefﬁcients of a Cox model towards zero by imposing
a penalty on their absolute values. It has a built-in feature selection
procedure while penalizing the parameters unlike L2 penalized Cox
regression with a quadratic penalty (ridge regression) [42,43] that
allows all coefﬁcients to be non-zero and may yield complex mod-
els. The objective of this shrinkage is to prevent overﬁtting occur-
ring by collinearity of the covariates. Thus we ﬁt the parameters b
of clinical variables xi for patient i by maximizing L1 penalized
partial log-likelihood (PPLL) deﬁned over the entire data with an
absolute value (lasso) penalty k on b as follows.
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¼
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3
5 k jj b j j1; ð10Þ
where k > 0 and ||||1 stands for the L1 norm. The zero value of k
means no shrinkage and the inﬁnity value indicates inﬁnite shrink-
age. In our study, we used the R package penalized to apply the lasso
implementation and used likelihood cross-validation for optimizing
the tuning parameter [18].
3.5. Proposed approach
3.5.1. Comparative scheme for the unbiased assessment of model
selection methods and the ﬁnal model for censored data
The framework of model building generally consists of (1) mod-
el selection for the ﬁnal model to ﬁnd a ﬁnal set of predictors or
determine tuning parameters for model complexity, (2) the ﬁnal
model and model selection method validation and assessment
using internal validation, and (3) the ﬁnal model building for the
practical use; including learning the parameter coefﬁcients of the
predictors that are found in the previous steps and its application
of the ﬁnal model to the external data sets (external validation).
For building a ﬁnal model using model selection, the common
procedure is to (1) use the whole data set for ﬁnding model com-
plexity parameters or for identifying a ﬁnal set of variables, instead
of using a test data held out for validation, and (2) proceed to esti-
mate the coefﬁcients of predictors, also using the data, for the sin-
gle ﬁnal model.
As for the unbiased assessment of the ﬁnal model, we need a ﬁ-
nal set of predictors, the resultant tuning parameters of the model
complexity in learning methods, and resampling techniques, such
as data splitting, cross-validation (CV), or bootstrapping. This
assessment scheme should be differentiated from that of model
selection methods for comparisons we used in the proposed meth-
odology as below.
The relative performance of a model within a variable selection
method may be subject to the variability of the training data on ac-
count of the EPV, selection bias, and right censoring in survival
data. Thus, we need the unbiased estimate of the true performance
of a variable selection method, and it can be achieved, using CV, by
the fact that all the aspects of the model development such as
model selection and parameter tuning should take place in the
training sets within the CV [34]. Although the Leave-one-out
cross-validation (LOOCV) and bootstrapping, in general, perform
well regarding bias, n-fold CV may be preferable to them due to
the lower computational cost [35]. In this reason, we employ the
CV as an outer loop for the assessment of variable selection meth-
ods and a nested CV of training folds within the outer CV for the
overoptimism correction. In order to make the best use of the
training data in variable selection, we randomly permute the data
for the repeated resampling and obtain the replicates of CV. Each of
the n-ﬁnal models of n-fold CV after model selection is tested on
the fold set left out for the independent evaluation and they are
averaged for the assessment of each method. The procedure of this
scheme is displayed in Table 3. For the best optimized ﬁnal model,
note that it is crucial to hold the ten EPV guideline in the develop-
ing step of model selection.
The two methods of stepwise with the likelihood ratio test and
the AIC are applied to this scheme without the resampling setting
of inner validation to compare with the proposed method.
3.5.2. Final model building through validation using STMC and FNSS
Our approach for variable selection consists of two stages. First,
Stepwise Tuning in the Maximum C-Index (STMC) begins from a
full model using the backward elimination. After a round of elim-ination, it reanalyzes the discarded variables one by one and allows
one more chance to be included in the current model. Using the n1-
fold outer CV, we obtain a set of n1 ﬁnal models with the different
sets of predictor variables ﬁtted to a training subsample and opti-
mized, using the k- replicates of n2-fold inner CV, for the maximum
C-Index. This might approximately represent the proportion of pre-
dictors in the ﬁnal model and is used for the interpretation of their
relative importance. As an overﬁtting control, numerous methods
use a regularization scheme (e.g. weight decay in Neural Net-
works), early stopping during repetition, or a Bayesian approach.
Instead of using early stopping in the ﬁrst stage, we achieve this ef-
fect in the second stage of Forward Nested Subset Selection (FNSS)
using variable ranking from the results of the distribution.
3.5.2.1. First stage:Stepwise Tuning in Maximum C-Index (STMC). The
STMC method we propose is in the class of wrapper methods
[36,37]. The C-Index is used for the performance evaluation of a
subset of predictors in the goodness of ﬁt. This kind of method
might produce correlated variables in a group of predictors of a
chosen model, but have the optimal performance. The iterative
process of variable selection can be viewed as performing the opti-
mization search in the model space. The search is performed over
ﬁnite models in a given model class for model selection. Given p
predictors, there are 2p possible variable subsets for the entire
search. It is usually very expensive to compare all combinations
for a large p and so typically some heuristic search procedure is
used to ﬁnd a local optimal good feature subset. We design the
STMC method based on the backward elimination scheme and give
one more chance for variables to reenter the model in the forward
direction. This process is repeated until all variables are visited.
The pseudo code of this procedure is shown in the STMC algo-
rithm of Table 4. Initially, a full model is assigned as a current best
model with the maximum C-Index, and a set of visited variables is
initialized to be empty. The repeat loop in the STMC algorithm is
comprised of (1) drop step, (2) add step, (3) comparison for choos-
ing an intermediate best model, and (4) stopping rule check (when
all variables are searched, break the iteration). The drop step (back-
ward direction) tests each predictor by comparing the current
model with a potential model whose size is one smaller than the
current model, and eliminate the most irrelevant predictor produc-
ing the smallest C-Index in the current best feature set when ex-
cluded from the current model. If there are no variables to win
over the current feature, no changes happen in the best model. In
the add step (forward direction), every element in the visit set of
discarded predictors is given a possibility to be reintroduced in
the current best model except for the element extracted from the
previous drop step. Between both models from the drop and add
step, the set of predictors with the greater C-Index is chosen. The
repetition stops when the procedure considers all predictors in
the pool of feature variables.
The n1-fold outer CV is used for the investigation of variable
selection having the uncertainty of different predictors and sizes.
This should be distinguished from the k -replicates of randomly
permuted training data sets and their internal n2-fold CV, with
which the generalization C-Index of each potential model is evalu-
ated by the sample re-use of k-replicates of the internal CV for the
purpose of the overoptimism correction. The STMC method yields
the distribution of predictors for a ﬁnal model. The inclusion fre-
quency of this distribution reﬂects the signiﬁcance of variables
and is represented by its proportion. The results of STMC are con-
nected to the ﬁlter type approach of FNSS at the next stage.
3.5.2.2. Second stage: Forward Nested Subset Selection (FNSS). The
proposed Forward Nested Subset Selection (FNSS) algorithm is a
ﬁlter type method [38], and is designed for controlling the overﬁt-
ting caused from model selection and for identifying a single ﬁnal
Table 3
The procedure for evaluating the performance of variable selection methods.
1. For each variable selection method:
(i) For each training data set obtained from n1-fold outer cross-validation
- Find the optimal set of predictors using k-replicates of n2-fold nested
cross-validation using the randomly permuted training data set
- Given the set, estimate the vector of regression coefﬁcients b on the
entire training data set
- Compute the values of several performance criteria (see Section 3.2) on
the test data set held out from outer cross-validation
(ii) Average the performance measures of n1 ﬁnal models built from (i)
2. Compare the different variable selection methods in terms of the criteria
values
Table 4
STMC algorithm.
Algorithm STMC
- Input : F, the set of variables in the full model
- Output : max, the ﬁnal set of variables in STMC
1. Initialize F = {1,. . .,p}, where p is the predictor size and visit = {£}, and let
max = F be the best subset.
2. Repeat
{
// a. Drop Step
for i = 1 to p
{
- if (i 2 F), Fi = F  {i}
- CVCI(Fi, k, N) // Estimate k-replicated N-fold cross validated C-Index to
evaluate only the predictors of Fi in Cox model
}
// Compare the best feature subset found in Drop Step with max, and set
max to be the subset with the greater C-Index
- if (MAX(CVCI(Fi, k, N)) > CVCI(max, k, N)) max = MAXFi (CVCI(Fi, k, N))
- visit = visit [ MAXi (CVCI(Fi, k, N))
- F = F MAXi(CVCI(Fi, k, N))
// b. Add Step
for j = 1 to length(visit)
{
- if (j 2 visit), Fj = F + {j}
- CVCI(Fj, k, N) // Estimate k-replicated N-fold cross validated C-Index to
evaluate only the predictors of Fj in Cox model
}
// Compare the best feature subset found in Add Step with max, and set
max to be the subset with the greater C-Index
if (MAXj(CVCI(Fj, k, N))>CVCI(max, k, N))
{
- max = MAXFj (CVCI(Fj, k, N))
- visit = visit – MAXj (CVCI(Fj, k, N))
- F = F [ MAXj (CVCI(Fj, k, N))
}
// c. Stopping rule check
- if (F = {£}) break the repeat iteration
}
3. Select and return the best feature subset, max which is evaluated during
the search space
⁄ MAX(CVCI(Fi, k)): a maximum value of CVCI(Fi, k)
⁄ MAXi (CVCI(Fi, k)): i with a maximum value of CVCI(Fi, k)
1 For interpretation of color in Figs. 4–6, the reader is referred to the web version of
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the inclusion frequency obtained in the previous stage. High score
variables are regarded as valuable, and they are sorted in the
decreasing order of the inclusion frequency. After variable ranking,
the FNSS builds models with increasing numbers of predictors
while incorporating a variable one by one from the null model
and evaluates each constructed model through the 10-fold cross-
validation based on the C-Index, the IAUC, the calibration slope,
the calibration curve, and the IBS. As our approach chooses the
C-Index as an objective metric, we select a set of variables with
the maximum C-Index as the ﬁnal model.
The R software version 2.8.1 [39] with the Design and survcomp
packages were used to perform all analyses and the proposedapproach is implemented with R package for free use (https://ﬁler.-
case.edu/ixc27/).4. Results of two case studies
4.1. Prostate cancer data
For variable selection methods in our study design, we use the
10-fold outer cross-validation to get information on variations in
the ﬁnal models of 10 training subsets and test them on each inde-
pendent test data set. The STMC algorithm uses the 10 replicated
5-fold inner CV for correcting overoptimism. Models are ﬁtted
using the Cox proportional hazards regression, and no interaction
or nonlinearity effect terms are assumed, and thus, none of them
are incorporated in the full model and other models as well. For
the comparison of models and selection methods, we achieve the
generalization measures of predictive performance: (i) the C-Index,
(ii) the integrated AUC (IAUC), (iii) the slope of prognostic index,
and (iv) the Integrated Brier Score (IBS).
Table 5 shows a comparative analysis for the performance of
model selection methods on prostate cancer data. The average
EPV of the training data sets in each method is 21.5, which is great-
er than 10 and is enough for eluding estimation bias, and the ex-
pected model size of each method is 4.8, 5.3, 6.2 and 5.1 for
likelihood ratio test (LRT), AIC, lasso, and STMC, respectively. All
of the performance measures of STMC are modestly the best on
the C-Index, IAUC, and PI slope. Lasso has a best score only on
the IBS and has a largest expected model size. A distribution of pre-
dictors, as a result of STMC, yields variable ranking in (a) of Fig. 2.
In particular, the variables of psa, ece, svi, pgx, and sm have a full
frequency of 10, whereas experience is not selected at all.
With FNSS, the optimization path based on C-Index is displayed
in Fig. 3 and the results of the other measures are also shown with
the corresponding values of discrimination, calibration, and overall
score. The open red1 circle indicates the performance measures of
the ﬁnal model optimized with maximum C-Index in FNSS. Note
that the IAUC has nearly a comparable pattern with the C-Index,
but the IAUC increases and reach to the full model of seven vari-
ables as opposed to the decrease of the C-Index. We can examine
this result numerically in Table 6, where the full model and the ﬁ-
nal model of FNSS are assessed and compared with four primary
measures, their development EPV, and the model size computed
by 10 CV. The EPV of FNSS grows from 21.5 to 30.04 by the reduc-
tion of the model size from 7 to 5. Except for the IAUC, most mea-
sures of the FNSS model are improved as reﬂected by increases in
the C-Index and the PI slope, and by decreases in the IBS. Table 1
also shows the estimated coefﬁcients and statistical signiﬁcance
of predictors in the multivariable Cox proportional hazards model
ﬁtted to the entire data on the prostate cancer data for the full
model and the ﬁnal model constructed by FNSS. All of the variables
in the FNSS model have signiﬁcant p-values at the 0.05 level.
The calibration curves of the full model and the FNSS model ap-
pear in Fig. 4. In order to plot the calibration curves of the actual vs.
predicted 10-year recurrence-free probability for internal valida-
tion, we use a splitting technique using two thirds of the whole
data for a training set and one third for a test set, where red aster-
isks represent the apparent calibration accuracy. In two plots, there
seems to be no signiﬁcant difference in training and test samples,
suggesting that it appears to be acceptable in re-substitution
results, but is a bit biased in test samples. Note that the results
of the plots are based on the speciﬁc follow-up-time of 10 years.this article.
Table 5
Comparative analysis for the performance of model selection methods on prostate cancer data and renal transplant data. Model selection methods are Stepwise likelihood ratio
test (LRT), Stepwise Akaike Information Criterion (AIC), lasso, and STMC (Stepwise Tuning in Maximum C-Index).
Dataset Prostate cancer data Renal transplant data
Model selection LRT AIC Lasso STMC LRT AIC Lasso STMC
Train. EPV 21.5 21.5 21.5 21.5 101 101 101 101
Exp. model size 4.8 5.3 6.2 5.1 7.8 10.1 12.6 7
C-Index 0.8043 (0.048) 0.8126 (0.062) 0.8100 (0.041) 0.8147 (0.057) 0.6763 (0.040) 0.6732 (0.038) 0.6768 (0.004) 0.6772 (0.036)
IAUC 0.8388 (0.046) 0.8532 (0.062) 0.8499 (0.044) 0.8552 (0.057) 0.7312 (0.014) 0.7284 (0.023) 0.7323 (0.024) 0.7356 (0.028)
PI Slope 0.9606 (0.026) 0.9542 (0.046) 0.9598 (0.036) 0.9606 (0.040) 0.9589 (0.027) 0.9530 (0.026) 0.9600 (0.034) 0.9635 (0.044)
IBS 0.1418 (0.018) 0.1390 (0.036) 0.1339 (0.032) 0.1375 (0.037) 0.0970 (0.010) 0.0970 (0.010) 0.0965 (0.010) 0.0968 (0.011)
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Fig. 2. Variable ranking of model distribution using Stepwise Tuning in Maximum C-Index (STMC) in (a) prostate cancer data and (b) renal transplant data.
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The same comparative and parameter schemes as used in the
prostate cancer data were applied to the renal transplant data.
Table 5 provides performance measures of the variable selection
methods of LRT, AIC, and STMC on the data set. The development
EPV is 101 for all methods alike and the average model size of
every method is reduced to approximately half of the full model
and the lasso produces a relatively somewhat complex model with
12.6. As with the prostate cancer data, STMC illustrates better per-
formance in all measures except for the IBS, whose value is the
largest for the lasso.
The results from the comparative scheme procedure of STMC
approximately yield the inclusion frequencies of predictors in the
ﬁnal model in (b) of Fig. 2. Only 10 variables are included in model
selection and the remaining 12 have zero proportions with no
information of ranking.
The optimization path of Fig. 5 shows the peaks on the same
place of the model size 7 in the IAUC and the C-Index, whose paths
have a similar pattern. The PI slope tends to decrease as the model
size increases and the IBS illustrates the sensitivity of the values to
the increasing model size.
As shown in Table 6, the ﬁnal model constructed from FNSS
consists of seven predictors, which are markedly reduced from
the 22 variables in the full model and, consequently, the EPV
augments from 101 to 329. The FNSS model is improved for every
measure, except for the IBS with the difference of 0.0001 from the
full model. In the plot of Fig. 6, the calibration of the prior fourgroups in the FNSS model is smoother than that in the full model
whereas the last group suffers from overestimation bias.
Finally, in Table 2 of the multivariable analysis of the full model
and the FNSS model, we can see that two p-values (recipient’s bmi
and donor’s age) change signiﬁcantly and conversely with the de-
crease of 0.525 to 0.034 and with the increase of 0.02 to 0.978,
respectively, and this illustrates the selection bias due to multi-col-
linearity between included variables and excluded ones.
5. A simulation study
In addition to two clinicopathologic datasets, we present a sim-
ulation study to demonstrate the effectiveness of the proposed ap-
proach in building a predictive model with simpliﬁed important
predictors. We simulate independent clinicopathologic data with
p = 30 variables and n = 2000 patients. All predictor values are gen-
erated from the uniform distribution [0, 1] and the true prognostic
index of a linear risk score function f(x) is formed by the coefﬁ-
cients of (10, 10, 7, 7, 3, 3, 1, 1, 0.3, 0.3) for
x = (x1,x2,. . .,x10)T. The remaining 20 variables of x11–x30 are not re-
lated to risk time-to-events. The survival time T is generated from
an exponential distribution with parameter exp(f(x)) when x is gi-
ven, and the censoring variable C is generated from an exponential
distribution with parameter 0.4. Then we obtain the survival data,
{(ti = min(Ti,Ci), di = I(Ti 6 Ci))|i = 1,. . .,n} with approximately 50% of
right censoring. We assume that the 30 variables represent the full
model. Using multivariate analysis, the variables x1–x8 related to
the time-to-event and the randomly generated variables of x17,
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Fig. 3. Optimization path of Forward Nested Subset Selection (FNSS) on renal prostate cancer data.
Table 6
Assessment and comparison of the full model and the ﬁnal model of Forward Nested
Subset Selection (FNSS).
Dataset Prostate cancer data Renal transplant data
Full Model FNSS Full Model FNSS
Train. EPV 21.5 30.04 101 329
Expected
Model
Size
7 5 22 7
C-Index 0.8141(0.063) 0.8153(0.057) 0.6742(0.040) 0.6857(0.039)
IAUC 0.8607(0.060) 0.8560(0.057) 0.7387(0.028) 0.7515(0.018)
PI Slope 0.9371(0.011) 0.9567(0.013) 0.9223(0.059) 0.9889(0.039)
IBS 0.1390(0.035) 0.1377(0.035) 0.0965(0.010) 0.0966(0.107)
I. Choi et al. / Journal of Biomedical Informatics 44 (2011) 595–606 603x19, and x30 are signiﬁcant at the level of 0.05. Our objective is to
ﬁnd a reduced model with the variables more relevant to survival
information that is at least as accurate as the full model. Table 7
shows the results of a simulation study that compares the perfor-
mance of the different model selection methods and ﬁnal models.
The 10 EPV rule for each model in the development step is held as
seen in Table 7.
The experimental results demonstrate that STMC moderately
outperforms the LRT and the AIC in most measures except the PI
slope and is better than the lasso except for the IBS measure. The
lasso has the poorest performance on the C-Index, IAUC, and PI
slope. For the expected model size, the LRT is over-simpliﬁed with
7.6, and the lasso built many complex models (of average size 18)
that often include many of the insigniﬁcant and non-relevant vari-
ables in x11–x30 (not shown). AIC models contain variables with the
size close to the true model but they are also inconsistently insig-
niﬁcant. STMC models always include the variables x1–x8 andmany of them have the size of 8. The performance of the ﬁnal mod-
el achieved by FNSS is also moderately better than the full model
and true model, and is reduced to a simple model with the eight
variables of x1–x8 although it does not include the variables of x9
and x10 that are not signiﬁcant but related to survival function.
Those variables seem to improve each score.6. Discussions and conclusion
Our speciﬁc goal of this study is to design a model selection
method that identiﬁes a statistical model that is optimally reduced
based on the C-Index. To achieve this goal, we have presented the
new approach of STMC and FNSS. Using STMC within 10-fold cross-
validation, we built 10 intermediate optimal ﬁnal models with the
subsets of predictors maximizing an objective criterion, C-Index
and we use the internal validation of 10 replicated 5-fold cross-
validation for optimism correction. Moreover, instead of using
the early stopping strategy that controls the loop number in STMC,
through the optimization path of FNSS, we handle the potential
overﬁtting problem of the STMC stage and the variability of chosen
candidate models.
The researchers [27] underline that numerical measures may be
difﬁcult to interpret depending on some situations and a model
with a good discriminative power will be most relevant for re-
search purposes. Besides, the censoring effect complicates the per-
formance measures of survival models, and we calculate several
measures categorized into discrimination (C-Index, IAUC), calibra-
tion (PI Slope and calibration curves), and the overall score (IBS). In
particular, the C-Index is emphasized as a primary accuracy mea-
sure of the proposed approach, due to its simplicity and efﬁciency.
As illustrated in our experiments of two data examples as well
as a simulation study using the comparative scheme of the model
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Fig. 5. Optimization path of Forward Nested Subset Selection (FNSS) on renal transplant data.
604 I. Choi et al. / Journal of Biomedical Informatics 44 (2011) 595–606selection methods and the ﬁnal model assessment, the proposed
approach demonstrates that STMC achieves better performance,
in the C-Index, IAUC and PI slope, than other methods. The lasso
method shows good performance on the IBS and yields a relatively
complex model. The ﬁnal model of FNSS, which yields a reduced
model, performs better than the full model in a majority of the
measures. On the simulation study, only a random experiment
was performed due to the restriction of the space and scope of this
article and we need a random experiment design for a comprehen-
sive study.
In the variable selection of survival models, the bias, which may
commonly occur in the traditional variable selection methods of a
survival data analysis, is (i) estimation bias, (ii) selection bias, and
(iii) censoring bias. We discuss, below, what the causes are and
how we overcome these kinds of bias in the proposed approach.
When an estimator converges, in probability, to the true param-
eter as the sample gets larger, it is said to be consistent, which indi-
cates that the estimator is unbiased in large samples. In the Cox
regression dealing with the time-to-event data, the event size is
much more essential than the sample size. The partial likelihood
of parameters in the Cox regression is maximized, especially over
event time, with respect to parameters and they can be estimatedby using some version of the Newton–Raphson algorithm. The
maximum partial log-likelihood estimation is consistent and unbi-
ased in a sufﬁciently large event size. Moreover, in connection with
the curse of dimensionality, a linear increase in the number of vari-
ables requires much of the event size geometrically. In general, as
the dimension increases, the estimation bias increases when the
event size is ﬁxed. This is because many subspaces of features
are sparse and empty. Therefore, in survival analysis, the sparse
sampling of time-to-event in high dimensions results in estimation
bias in time-to-event modeling of censored data. Especially, in the
literature of survival analysis, a small data is deﬁned by one with
less than 10 EPV [12]. Some references emphasize the ratio of
one to ten to prevent the estimation bias. Furthermore, although
the EPV is sufﬁciently large, if there is multi-collinearity among
independent variables, the parameter estimates remain unbiased
but their variances can be large. To somewhat alleviate the prob-
lem of the estimation bias, we attempted to correct for the overop-
timism using 10 replicated 5-fold cross-validation for internal
validation [10]. Also, since the estimation under multi-collinearity
can be unstable in each learning phase of the variable selection
method using p-values, this can aggravate the predictive accuracy
and may add selection bias during the iteration process. However,
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Table 7
A simulation study for the performance evaluation of model selection methods: LRT (likelihood ratio test), AIC (Akaike Information Criterion), lasso, and STMC (Stepwise Tuning in
Maximum C-Index), and the ﬁnal models: the full model, the true model, and FNSS (Forward Nested Subset Selection).
Comparison Method Final model
Model selection LRT AIC Lasso STMC Full model True model FNSS
(x1–x30) (x1–x10) (x1–x8)
Train. EPV 127.24 94.06 31.44 105.43 31.98 95.94 119.93
Exp. model size 7.6 10.2 18 9.1 30 10 8
C-Index 0.6986 (0.014) 0.6957 (0.014) 0.6933 (0.030) 0.7016 (0.014) 0.6898 (0.020) 0.7023 (0.013) 0.7025 (0.013)
IAUC 0.7481 (0.020) 0.7462 (0.019) 0.7460 (0.039) 0.7530 (0.020) 0.7401 (0.018) 0.7485 ((0.017) 0.7537 (0.019)
PI Slope 0.8825 (0.042) 0.8773 (0.035) 0.8771 (0.048) 0.8790 (0.097) 0.7943 (0.035) 0.8356 (0.058) 0.8620 (0.019)
IBS 0.1661 (0.040) 0.1663 (0.040) 0.1648 (0.021) 0.1651 (0.040) 0.1674 (0.025) 0.1663 (0.026) 0.1659 (0.026)
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the ﬁnal model with a set of predictors optimized for predictive
accuracy.
The problem of the censoring bias can be considered via the
time-dependent measures such as IAUC and IBS, where the infor-
mation prior to the right censoring of lost to follow-up is used to
compute the values over time. Due to the time complexity of the
IAUC and the sensitivity to censoring of the IBS, the concordance
index is used in our approach for its efﬁciency, and it tends to have
a similar pattern to the IAUC.
Nonlinear or interaction terms can be considered in the multi-
variable Cox proportional hazards regression to improve model
bias but this ﬂexibility may suffer from overﬁtting. We can handle
the problem of the model complexity by the structured model that
applies the kernel trick or structured functions giving nonlinear ef-
fects [40]. Some authors have proposed multivariable fractional
polynomial models using backward elimination with an adaptive
algorithm and have compared it with a nonparametric approach,
generalized additive models (GAMs) using cubic smoothing splines
[41]. They state that the method can have a risk of overﬁtting prob-
lem and stress that the functional form of the ﬁnal model should be
consistent with medical knowledge. Also, for a more accurate cal-
ibration, an appropriate baseline survival function may be required
to be speciﬁed along with the assumption checking and this may
be used in an objective function, which should be less inﬂuenced
by censoring, for assessing the performance of a model, sincediscrimination measurement depends on the order of the predicted
survival rates.
We have strived to reduce overoptimism using resampling
methods in our algorithms and could ﬁnd a stable set of predictors
for the ﬁnal model. Practically, the prediction of a new patient may
still have a variance problem and may be inaccurate and biased for
only a single ﬁnal model. Ensemble methods, which build numer-
ous simpler base models and combine their advantages for a single
prediction model, can be designed for the survival model in regres-
sion problem.
For the further study, we are investigating the integration of
clinicopathologic and genomic data in censored survival analysis.
The researchers [42,43] show that, in most of data in the results,
the L2 penalized method (ridge) produced the better performance
than the lasso whose computational cost is very high. However,
the ridge method uses the full predictors without parsimony. Fur-
thermore, in the data fusion studies of clinico-genomic data [43],
the L2 penalized method tends to show little improvement in clin-
ical predictors rather than genomic ones. The concern of this re-
search might be to develop a statistical and computational
algorithm that ﬁnds the combined ﬁnal model with high accuracy
and parsimony.
In conclusion, our new proposed approach constructed the
accurate ﬁnal models with the optimally reduced size of risk fac-
tors through validation using resampling-based techniques. The
proposed method, STMC, compared to the stepwise selection
606 I. Choi et al. / Journal of Biomedical Informatics 44 (2011) 595–606methods with the different criteria of the LRT and the AIC, and las-
so, demonstrated better results in the two different data sets and a
simulation study, and can be used for prognostic modeling. The ﬁ-
nal model of FNSS improved the C-Index at least better than the
full model and had better performance in most measures.
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